期刊文献+

肥大细胞增生症与干细胞因子受体(c-kit)突变的关系 被引量:8

下载PDF
导出
摘要 肥大细胞增生症是一组多种病理机制的疾病,近年来发现c- kit活化性突变也是肥大细胞增生症的一个重要机制,对肥大细胞的增殖和致瘤性有重要作用。c -kit活化性突变和某些肥大细胞增生症临床类型有关。酪氨酸激酶抑制剂等及影响c- kit表达的因素可能会对有c- kit突变的肥大细胞增生症有治疗作用。
作者 吴贤杰 郑敏
出处 《国外医学(生理病理科学与临床分册)》 2005年第1期87-90,共4页 Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
  • 相关文献

参考文献30

  • 1Ashman LK. The biology of stem cell factor and its receptor c-kit[ J]. Int J Biochem Cell Biol, 1999, 31 (10) : 1037-1051.
  • 2Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product[J]. J Clin Invest, 1993, 92(4) : 1736-1744.
  • 3Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder[ J ]. Proc Natl Acad Sci USA, 1995,92(23) : 10560-10564.
  • 4Longley B J, Tyrrell L, Lu SZ, et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm [ J ]. Nat Genet,1996, 12(3) : 312-314.
  • 5Pignon JM, Giraudier S, Duquesnoy P, et al. A new c-kit mutation in a case of aggressive mast cell disease[J]. Br J Haematol, 1997,96 ( 2 ) : 374-376.
  • 6Longley BJ, Reguera MJ, Ma Y. Classes of c-kit activating mutations: proposed mechanisms of action and implications for disease classification and therapy [ J ]. Leuk Res, 2001, 25 (7) : 571-576.
  • 7Chan PM, Ilangumaran S, La Rose J, et al. Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region [ J ].Mol Cell Biol, 2003, 23 (9) : 3067-3078.
  • 8Hashimoto K, Matsumura I, Tsujimura T, et al. Necessity of tyrosine 719 and phosphatidylinositol 3 '-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation[J]. Blood, 2003, 101(3) : 1094-1102.
  • 9Piao X, Paulson R, van der Geer P, et al. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1 [ J ].Proc Natl Acad Sci USA, 1996, 93(25) : 14665-14669.
  • 10Shivakrupa R, Bemstein A, Watring N, et al. Tidylinositol 3'-kinaseis required for growth of mast cells expressing the kit catalytic domain mutant[J]. Cancer Res, 2003, 63(15) : 4412-4419.

同被引文献50

  • 1赵雪莲,王军,汤有才,王西阁,王伟,孟晓晖,王宏,冯建飞.儿童再生障碍性贫血干细胞因子及受体的表达[J].医药论坛杂志,2005,26(5):14-15. 被引量:1
  • 2汤耀卿.代谢性碱中毒的治疗策略[J].外科理论与实践,2006,11(1):1-3. 被引量:3
  • 3魏兆甫.肠易激综合征及其治疗[J].中国基层医药,2006,13(10):1745-1746. 被引量:8
  • 4陈西勇,阴琳琳.肠易激综合征的诊治新进展[J].社区医学杂志,2007,5(04S):38-39. 被引量:13
  • 5杨云生,周殿元,张万岱,张振书,宋于刚.肠易激综合征回盲部肥大细胞的研究[J].中华内科杂志,1997,36(4):231-233. 被引量:47
  • 6Vliagoftis H, Worobec AS, Metcalfe DD, et al. The protooncogene e-kit and e kit ligand in human disease. Allergy Clin Immu nol. 1997,100 : 435-440.
  • 7Barczyk M,Debek W,Chyczewski L. Mast cells in the gastrointestinal tract. Roczniki Akademii Medycznej w Bialymstoku, 1995,40 : 36-57.
  • 8OSullivan M, Clayton N, greslin NP,et al. Increased mast ceils in the irritable bowel syndrome. Neurogastroemerol Motil, 2000,12 : 449-457.
  • 9Park JH,Rhee PL,Kim HS,et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol HepatoI, 2006, 21 :71-78.
  • 10Talley NJ,Butterfield JH. Mast cell infiltralion and degranulation in colonic mucosa in the irritable bowel syndrome, Am J Gastroenterol, 1996, 91:1675-1676.

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部